ENTITY
Aurobindo Pharma

Aurobindo Pharma (ARBP IN)

137
Analysis
Health Care • India
Aurobindo Pharma Limited manufactures and markets oral and sterile antibiotics, antibacterials, anti-ulcerants and other generic basic drugs. Products include semi-synthetic penicillin drugs like ampicillin and amoxycillinas well as antibiotics, which include cloxacillin and dicloxacillin. The Company also manufactures formulations like astemizole, domeperidone and omeprazole.
more
•03 May 2024 07:22•Broker

Axis Top Picks - May 2024

The Axis Top Picks Basket delivered an excellent return of 5.8% in Apr’24 against the 1.2% return posted by Nifty 50, thereby beating the benchmark...

Logo
323 Views
Share
bullish•Aurobindo Pharma
•05 Mar 2024 06:31•Broker

Pick of the Week - Aurobindo Pharma Ltd - 04 MAR 2024

The company is engaged in the development, manufacturing, and commercialization of a wide range of generic pharmaceuticals, branded specialty...

Logo
361 Views
Share
•22 Feb 2024 22:44•Broker

Pharma Sector: Q3FY24 Review

EBITDA margin witnessed a healthy improvement of 220bps YoY and 55bps QoQ, attributed to normalizing cost inflation and stabilizing prices.

Logo
368 Views
Share
•16 Feb 2024 08:29•Broker

Valuation of Indices: All Indices and Most Sectors in the Overheated Zone

Over the last year, the key benchmark indices Nifty 50, Nifty Midcap 100 and Nifty Small-Cap 100 have delivered returns of 22%, 56% and 66%...

Logo
378 Views
Share
•24 Jan 2024 07:34•Broker

Pharmaceuticals: US Generic Growth to Stay, Selective on Structural Play

The pharmaceutical sector, emerging from the volatility of the past two post-pandemic and geopolitically tumultuous years, is now on a recovery...

Logo
296 Views
Share
x